AI assistant
Sending…
Terns Pharmaceuticals, Inc. — Director's Dealing 2024
Nov 20, 2024
32559_dirs_2024-11-19_b437619a-59fd-4d9b-950e-52258739082d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Terns Pharmaceuticals, Inc. (TERN)
CIK: 0001831363
Period of Report: 2024-11-18
Reporting Person: Turner Heather D (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-11-18 | Stock Option (Right to Buy) | $5.70 | A | 64000.00 | Acquired | 2034-11-17 | Common Stock (64000.00) | Direct |
Footnotes
F1: 1/3rd of the shares subject to the option vest on the first anniversary measured from November 18, 2024 (the "Vesting Commencement Date"), and 1/36th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested on the third anniversary of the Vesting Commencement Date.